Glycosmis parva CRAIB (Rutaceae) is a wild small shrub distributed in Thailand.
Biological activities of acridone alkaloids were reported such as antimalarial activity, 3) anti-herpes simplex virus (HSV) activity, 4) tumor cell growth inhibition, 5) suppression of human immunodeficiency virus type 1 (HIV-1) replication, 6) induction of human promyelocytic leukemia (HL-60) cellular differentiation, 7) antiproliferative activity, 8) cancer chemopreventive activity, 9) and modulation of P-glycoprotein activity. 10) For sulfur-containing propanamides, antifungal activities were mainly reported. 11) We examined the crude extracts of the branches and leaves of G. parva focused on anti-HSV activities against HSV-1 and HSV-2 and observed positive activities. In this paper, we report the structure elucidation of a new acridone alkaloid, glycosparvarine (1) , two new N-[(4-monoterpenyloxy)phenylethyl]-substituted sulfur-containing propanamide derivatives, S-deoxydihydroglyparvin (10) and S-deoxytetrahydroglyparvin (11) , which were isolated together with nine known compounds, and the anti-HSV activity of the isolates.
Results and Discussion
The MeOH extracts of the branches and the leaves of G. parva were partitioned with hexane. The remaining layers were further partitioned with EtOAc and n-BuOH after addition of water. Organic extracts were subjected to antiviral activity tests in plaque reduction assays against HSV-1 and HSV-2. The hexane and EtOAc extracts from branches, and the hexane extract from leaves displayed the anti-herpes virus activities in the inactivation inhibition, while the EtOAc extract from leaves exhibited the anti-herpes virus activities in both inactivation treatment and post-inhibition (Table 1) .
Repeated chromatographies of the EtOAc extract of branches using the solvent systems of MeOH-CHCl 3 , acetone-hexane, and acetone-CHCl 3 led to the isolation of a new acridone alkaloid, glycosparvarine (1) (Fig. 2) . These data allowed us to deduce the alignment of 1,3,5-trihydroxy-2-methoxy substituents. Thus, glycosparvarine (1) was reasonably deduced to be 1,3,5-trihydroxy-2-methoxy-N-methyl-9-acridone.
The pseudo molecular ion ([MϩH] (Table 2) showed three tertiary and one secondary methyl groups, and two ethylene units, one of which was connected to the root of the secondary methyl group, in the aliphatic proton region. In the lower field, the spectrum were observed seven protons, six of which were assignable (Table 2) supported the above assignments and showed the presence of one additional quaternary carbon (d C 88.6). These spectral data were similar to those of a known dihydroglyparvin, 22) which was formally composed of monoterpene, p-hydroxyphenethylamine, and trans-b-methylsulfonylacrylic acid subunits, except the surrounding of sulfur atom. The presence of 5-(1-methylpropyl)-3(2H)-furanone system as a monoterpene unit was suggested by HMBC correlations of d Vol. 57, No. 11 (Fig. 3) .
S-Deoxydihydroglyparvin (10) and S-deoxytetrahydroglyparvin ( Co-isolation of a known (ϩ)-dihydroglyparvin (13), lacking the sulfur chiral center, 22) suggested that the carbon chiral center of the monoterpene units in these three might be the same absolute stereochemistry, even remaining unknown. (ϩ)-Entadamide C had been isolated from Entada phaseoloides as a related and simple b-methylsufinylcarboxyamide derivative, and the absolute configuration of the sulfur atom had been reported to be an R configuration. 25) Thus, the positive sign of [a] D in 10 and 11 could suggest the same R-configuration of the sulfur chiral center which is in (ϩ)-entadamide C. We will independently carry out the asymmetric synthesis of these S-deoxyglyparvin derivatives for the establishment of the chiral centers.
Anti-HSV activities against HSV-1 and HSV-2 of the isolates (1-13) were assessed (Table 3) . Glycofolinine (4) exhibited moderate activity with EC 50 of 151 mM against both HSV-1 and HSV-2 in inactivation treatment and post-treatment, and the 50% cytotoxic concentration (TC 50 ) to the cells used in assay was 453 mM. A new alkaloid, glycosparvarine (1), also exhibited activity even with higher EC 50 (348 mM). In 3-methylacridone series structure-activity relationship (SAR) for anti-herpes virus activity has been suggested the responsibility of the hydroxyl group at either the C-5 or C-6 positions such as citpressine-I and citrusinine-I. 4) Furthermore, potential anti-herpes virus activity has been observed in the 2,2-dimethylpyranoacridones. 4) Our studies showed that oxygen-substituted acridones could act as an additional acridone potential for anti-HSV activity.
In addition to N-[(4-monoterpenyloxy)phenylethyl]-substi-
tuted sulfur-containing propanamide derivatives, S-deoxydihydroglyparvin (10) exhibited antiviral activities against HSV-1 and HSV-2 with EC 50 of 29.8 and 44.6 mM in activation treatment and post-treatment, respectively. However, the EC 50 of 10 was close to the TC 50 (89.4 mM). S-Deoxytetrahydroglyparvin (11) showed no activity at concentration tested (100 mg/ml) in inactivation treatment and post-treatment. In contrast, glyparvin-A (12) and dihydroglyparvin (13) showed no activity at the non-toxic concentration. The limonoid-type compounds (7 and mixture of 8 and 9) showed no activity against HSV-1 and HSV-2.
In conclusion, six acridone alkaloids including a new glycosparvarine (1), three limonoids, and four N-[(4-monoterpenyloxy)phenylethyl]-substituted sulfur-containing propanamide derivatives including two new species, S-deoxydihydroglyparvin (10) and S-deoxytetrahydroglyparvin (11), were isolated from the branches and the leaves of G. parva collected in the east of Thailand. Antiviral activity evaluation of isolates against HSV-1 and HSV-2 disclosed the moderate activity of glycosparvarine (1) and glycofolinine (4) . In addition, S-deoxydihydroglyparvin (10) exhibited anti-HSV activity at the lower concentration which was close to the cytotoxic concentration.
Experimental
General Procedures Melting points were measured on a micromelting point hot-stage apparatus (Yanagimoto) and are uncorrected. UV spectra were recorded on a JASCO V-530 UV spectrophotometer. IR spectra were recorded on a JASCO IR-230E spectrophotometer. Optical rotations were recorded on a JASCO P-1020 polarimeter. EI-MS and HR-EI-MS were measured on a JEOL GC-Mate spectrometer. FAB-MS and HR-FAB-MS were obtained by JEOL JMS-AX 500 and JEOL JMS-HX 110 spectrometers, respectively. HSV-1 HSV-2 HSV-1 HSV-2 1 -100 mg/ml Ͼ100 mg/ml 100 mg/ml Ͼ100 mg/ml Ͼ100 mg/ml (348 mM) (348 mM) (348 mM) (348 mM) (348 mM
10 -12.5 mg/ml 18.7 mg/ml 12.5 mg/ml 18.7 mg/ml 37.5 mg/ml (29.8 mM) (44.6 mM) (29.8 mM) (44.6 mM) (89. (NSR 510209) has been deposited at the Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Thailand.
Extraction and Isolation
The dried branches (B) (12.35 kg) and leaves (L) (4.8 kg) were ground and macerated with MeOH (4ϫ30 l for B; 4ϫ10 l for L). The MeOH extracts (850 g for B; 650 g for L) were partitioned with hexane to obtain the hexane extracts (72 g for B; 135 g for L). The remaining layers were added with water and further partitioned with EtOAc to yield the extracts (321 g for B; 100 g for L) . The aqueous layers were partitioned with n-BuOH to give the extracts (85 g for B; 93 g for L) .
The EtOAc extract (29.34 g) of branches was subjected to CC eluted with a gradient solvent system of MeOH-CHCl 3 (0%, 1%, 2%, 5%, 10%, 20%, 30%, and 100% MeOH/CHCl 3 ) to give thirteen fractions (BE1-BE13). BE4 (7.00 g) was washed with Et 2 O to obtain 2 (0.85 g) and the soluble part (4.04 g) was purified by CC (20-100% Me 2 CO/hexane) to give ten subfractions (BE4-1-BE4-10) . Washing of BE4-3 (0.30 g) with Et 2 O and separation of BE4-5 (0.39 g) by CC (20% Me 2 CO/hexane) afforded 3 (35 mg) and 4 (19 mg), respectively. Fraction BE5 (0.50 g) was separated into twelve sub-fractions (BE5-1-BE5-12) by CC (20-30% Me 2 CO/hexane). Further purification of BE5-9 (0.11 g) by CC (20-30% Me 2 CO/hexane) gave 7 (6.5 mg) and a mixture of 8 and 9 (8 mg). BE6 (0.15 g) was purified by CC (30-40% Me 2 CO/hexane) to give 5 (10.6 mg). After washing of BE9 (0.59 g) with Et 2 O, the soluble part (0.28 g) was subjected to CC (2% Me 2 CO/CHCl 3 ) to afford 1 (6.8 mg).
The EtOAc extract (11.60 g) of leaves was washed with CH 2 Cl 2 . After removal of the insoluble part, a soluble part (5.38 g) was purified by CC (0%, 0.5%, 1%, 2%, 5%, 10%, 20%, 30%, and 100% MeOH/CHCl 3 ) to afford twelve fractions (LE1-LE12). Washing of LE3 (1.02 g) with Me 2 CO followed by recrystallization from CH 2 Cl 2 -Me 2 CO gave 6 (122.7 mg) as yellow needles, mp 181°C (lit. 16) mp 177-178°C). LE5 (550 mg) was separated to five fractions (LE5-1-LE5-5) by Sephadex LH-20 column chromatography using 50% MeOH/CHCl 3 . A part (79 mg) of LE5-3 (260 mg) was washed with Et 2 O, followed by recrystallization from CH 2 Cl 2 -Et 2 O, to afford 12 (15 mg) as colorless needles, mp 136-138°C (lit. 15) mp 134-137°C). The evaporated supernatant (44 mg) was purified by repeated CC using different solvent systems (4% MeOH/CHCl 3 , 60-70% EtOAc/hexane, and 45% EtOAc/CHCl 3 ) to afford 13 (8 mg). LE6 (1.13 g) was separated to nine fractions (LE6-1-LE6-9) by Sephadex LH-20 column chromatography using 50% MeOH/CHCl 3 . After removal of the soluble fraction of LE6-5 (184 mg) in CH 2 Cl 2 -Et 2 O, the solid (60 mg) was subjected to flash CC (40% Me 2 CO/hexane) to give 10 (28 mg).
A part (357 mg) of LE7 (669 mg) was separated to six fractions (LE7-1-LE7-6) by Sephadex LH-20 column chromatography using 50% MeOH/ CHCl 3 . LE7-3 (255 mg) was purified by CC (2% MeOH/CHCl 3 ) to afford six fractions (LE7-3-1 to LE7-3-6). LE8 (244 mg) was separated to six fractions (LE8-1-LE8-6) by Sephadex LH-20 column chromatography using 50% MeOH/CHCl 3 . After LE7-3-4 (70 mg) and LE8-4 (187 mg) were combined, the whole was separated by CC (3%, 4%, 10%, 20%, 30%, and 100% MeOH/CHCl 3 ) to afford eight fractions, the third fraction (94 mg) of which was subjected to recycling preparative HPLC followed by double CC (2% MeOH/CHCl 3 ) to afford 11 (15 mg cϭ0.04, CHCl 3 ). Viruses and Cells HSV strains used were HSV-1 (KOS) and HSV-2 (Baylor186). Vero cells (ATCC CCL81) were grown and maintained in Eagle's minimum medium supplemented with 10% fetal bovine serum.
Plaque Reduction Assay Anti-HSV activity of the compound was determined by plaque reduction assay modified from the reported method. 26) Briefly, in post-treatment assay, Vero cells, in 96-well tissue culture plate, were infected with 30 plaque forming units of HSV-1 (KOS) or HSV-2 (Baylor186). After 1 h incubation at room temperature for virus adsorption, the cells were added with overlay media containing various concentrations of the compound. The infected cultures were incubated at 37°C for 2 d. The infected cells were fixed and stained, and then the number of plaques was counted. The 50% effective concentration (EC 50 ) was determined from the curve relating the plaque number to the concentration of the compound. Acyclovir was used as a positive control. In inactivation assay, each of 30 plaque forming units of HSV-1 (KOS) or HSV-2 (Baylor 186) was mixed with various concentrations of compound and incubated for 1 h, then the mixture was added to Vero cells in 96-well tissue culture plate. After 1 h incubation for virus adsorption, the overlay media were added. The infected cultures were incubated at 37°C for 2 d. The infected cells were fixed, stained, and the plaques were counted. The 50% effective concentration (EC 50 ) was determined.
